<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:chebi fb="1" ids="6495">Lipoprotein</z:chebi> concentrations are associated with the development of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in people with and without <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The relative strength of these associations could differ by <z:mp ids='MP_0002055'>diabetes</z:mp> status as a result of <z:mp ids='MP_0002055'>diabetes</z:mp>-related <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> modifications </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: The associations between <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> concentrations and internal and common carotid artery intimal-medial thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) assessed by B-mode ultrasonography were examined by <z:mp ids='MP_0002055'>diabetes</z:mp> status in a cross-sectional analysis among 1,391 participants in the <z:hpo ids='HP_0000855'>Insulin Resistance</z:hpo> <z:hpo ids='HP_0002621'>Atherosclerosis</z:hpo> Study </plain></SENT>
<SENT sid="3" pm="."><plain>Participants included 442 individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, 308 with <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo>, and 641 with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The differences in internal and common carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> between the highest and lowest tertiles of <z:chebi fb="15" ids="39026">LDL</z:chebi> were 58.1 microm (P = 0.054) and 51.0 microm (P &lt; 0.001), respectively </plain></SENT>
<SENT sid="5" pm="."><plain>The differences in internal and common carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> between the lowest and highest tertiles of <z:chebi fb="17" ids="39025">HDL</z:chebi> were 56.2 microm (P = 0.07) and 37.8 microm (P = 0.003), respectively <z:chebi fb="4" ids="17855">Triglycerides</z:chebi> and <z:chebi fb="1" ids="39027">VLDL</z:chebi> were not associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>These associations did not differ significantly because of <z:mp ids='MP_0002055'>diabetes</z:mp> status </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These results support the importance of <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> as a major risk factor for <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in people with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Future research in humans should measure <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> oxidizability, glycation, size, and composition directly in people of differing <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance status to address the importance of <z:mp ids='MP_0002055'>diabetes</z:mp>-related <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> modifications more conclusively </plain></SENT>
</text></document>